On 27 October 2025 and 6 March 2026, Lanxess Deutschland GmbH submitted to the Agency, in accordance with Article 11(1) of Implementing Regulation (EU) No 354/2013, notifications of administrative changes to the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’, as referred to in Title 1 of the Annex to that Regulation. The notifications were recorded in the Register for Biocidal Products under case numbers BC-NY111447-09 and BC-NG116317-45. The notified proposed changes to that authorisation concern the addition of product manufacturers and trade names.
Recital 4, Regulation (EU) 2026/2024
In forcesince 10 Sep 2026